FDA Inspection
Berman, Gary D., MD, Clinical InvestigatorBerman, Gary D., MD, Clinical Investigator – FDA Inspection, Mar 29, 2021
Record Details
This FDA Inspection record concerns Berman, Gary D., MD, Clinical Investigator, with an inspection on March 29, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 29, 2021
- Product Type
- Biologics
View Company Profile
ID · 072c9bc0-b1bd-426f-aaaf-324fc2259dbd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1137255
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Berman, Gary D., MD, Clinical Investigator
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2013 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Berman, Gary D., MD, Clinical Investigator
- FDA Inspection 841024 - 2013-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.